Your browser doesn't support javascript.
loading
Antimutagenic effects of taurine in a bacterial assay system.
Laidlaw, S A; Dietrich, M F; Lamtenzan, M P; Vargas, H I; Block, J B; Kopple, J D.
Afiliação
  • Laidlaw SA; Department of Medicine, School of Medicine, Harbor-UCLA Medical Center, Torrance 90509.
Cancer Res ; 49(23): 6600-4, 1989 Dec 01.
Article em En | MEDLINE | ID: mdl-2479467
ABSTRACT
Taurine (2-aminoethanesulfonic acid) was evaluated as an antimutagen in the Ames Salmonella tester strain assay. Taurine inhibited mutagenesis by doxorubicin (-74%), bleomycin (-55%), mitomycin C (-56%), and 2-aminofluorene (-52%), but not danthrone or benzo(a)pyrene, in strain TA102. In strain TA98, doxorubicin mutagenicity, but not that of 2-aminofluorene or benzo(a)pyrene, was inhibited by taurine. N-Methyl-N'-nitro-N-nitrosoguanidine (-73%), but not dexon, mutagenicity was inhibited by taurine in strain TA100. Taurine inhibited those mutagens against which it was effective in a dose-related fashion. Taurine was more effective in inhibiting doxorubicin mutagenicity in strain TA102 than its analogues hypotaurine, beta-alanine, and guanidinoethanesulfonic acid or alanine or glycine. The observed inhibition may indicate a role for taurine in modulating the activity of oxidant species.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Taurina / Mutagênicos Idioma: En Revista: Cancer Res Ano de publicação: 1989 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Taurina / Mutagênicos Idioma: En Revista: Cancer Res Ano de publicação: 1989 Tipo de documento: Article